Abstract:Aims: To investigate the relationship between N-terminal pro-B-type natriuretic peptide (NT-proBNP), Glomerular Filtration Rate (GFR), and outcomes in patients hospitalized with acute heart failure (AHF). Methods: The trial was registered at http://www.chictr.org/cn/. (ChiCTR - ONC - 12001944). A total of 493 patients hospitalized for AHF in cardiology department of the First Affiliated Hospital of Nanjing Medical University from March 2012 to October 2016 were enrolled into registry. The end event was the occurrence of all-cause death within an 18-month follow-up. The data collected from the participants in admission were used to calculate the GFR by chronic kidney disease epidemiology collaboration equation (CKD-EPI) and performed the according statistical analysis. Results: There were 74 participants (13.8%) dropped out and 91 (21.7%) passed away within the 18-month follow up. Comparison of clinical indicators between survival and death group were analyzed for the long-term prognosis of patients with AHF. In the single factor analysis, both NT-proBNP and GFR were statistically significant (P < 0.001). Combined NT-proBNP and GFR in multi-factor COX regression analysis showed significant predictive value (P < 0.001). In receiver operator characteristics (ROC) analyses, the area under the curves (AUC) for NT-proBNP was 0.648 [95%CI: 0.598-0.695, P < 0.001] and for GFR was 0.677 [95%CI: 0.627-0.723, P < 0.001]. According to the Youden index, the best prediction point of NT-proBNP was 2,137 pg/ml and GFR was 61.7 ml/(min·1.73 m2). After using the Binary Logistic Regression to combine the two indicators, the AUC was 0.711, which was significantly compared to the AUC of either single factor. The sensitivity of the combined indicators were 0.535, the specificity were 0.853. According to the cut-off point, these two indexes were separated into four groups for further analysis by Kaplan-Meier survival curve comparison (log-rank test), which showed that patients in the group with higher NT-proBNP and lower GFR had the worst prognosis. Conclusions: In patients with NT-proBNP > 2,137 pg/ml and GFR < 61.7 ml/(min·1.73 m2), the risk of death was significantly higher. The combination of GFR and NT-proBNP improved the predictive value for the long-term prognosis of AHF patients.

Relationship between N-terminal pro-brain natriuretic peptide and heart failure

Relationship between the extent of coronary artery lesions and plasma brain natriuretic peptide

Changes of blood N-terminal fragment of brain natriuretic peptide prohormone in patients with chronic heart failure

Corelation Between Plasma N-terminal ProBNP(NT-proBNP) and Cardiac Dysfunction

The Application of N-terminal Pro-brain B-type Natriuretic Peptides in the Diagnosis of Elderly Patients with Chronic Heart Failure

Influencing factors for plasma natriuretic peptide and N-terminal pro-B-type natriuretic peptide levels in senior patients with heart failure

Clinical application and evaluation of N-terminal pro-Brain natriuretic peptide quantitative detection in heart failure laboratory diagnosis

The Effectiveness of NT-proBNP in Diagnosing Heart Failure

Prognostic value of N-terminal B-type natriuretic peptide in patients with chronic heart failure

Significance of NT-proBNP Level in Patients with Heart Failure after Interventional Treatment and Value Prediction on Myocardial Function

Values of plasma N-terminal pro-B-type natriuretic peptide in severity assessment and prognostic prediction for chronic heart failure in the elderly

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and Glomerular Filtration Rate in Patients with Acute Heart Failure

Clinical Research of Relationship Between N-terminal Pro-Brain Natriuretic Peptide Levels and Cardiovascular Events in Maintenance Hemodialysis Patients

The Relationship between Cardiac Hemodynamics and the Level of Plasma NT-proBNP in Patients with Acute Coronary Syndrome

Clinical value of N-terminal proBNP in diagnosis of left heart failure

Determination of N-terminal Pro-Brain Natriuretic Peptide and Other Biochemical Markers in Elderly Patients with Chronic Heart Failure

Clinical evaluation effect of brain natriuretic peptide in patients with heart failure

NT-proBNP Levels in Cardiovascular Disease and Its Comparison with Others Biochemical Indicators

Relevance of Brain Natriureticpeptide Level and Cardiac Function in Heart Failure Patients

Correlation of NT-proBNP levels with liver function in patients with chronic congestive heart failure

Plasma Brain Natriuretic Peptide Levels in the Diagnosis of Heart Failure